Search bioRxivSearch

Biology subjects

Madaj, R.

Publications and source records attributed to Madaj, R..

3 recordsLinked to original sources

Graph neural networks and sequence embeddings enable the prediction and design of the cofactor specificity of Rossmann fold proteins

The Rossmann fold enzymes are involved in essential biochemical pathways such as nucleotide and amino acid metabolism. Their functioning relies on interaction with cofactors, small nucleoside-based compounds specifically recognized by a conserved {beta}{beta} motif shared by all Rossmann fold proteins. While Rossmann methyltransferases recognize only a single cofactor type, the S-Adenosylmethionine (SAM), the oxidoreductases, depending on the family, bind nicotinamide (NAD, NADP) or flavin-based (FAD) cofactors. In this study, we show that despite its short length, the {beta}{beta} motif unambiguously defines the specificity towards the cofactor. Following this observation, we trained two complementary deep learning models for the prediction of the cofactor specificity based on the sequence and structural features of the {beta}{beta} motif. A benchmark on two independent test sets, one containing {beta}{beta} motifs bearing no resemblance to those of the training set, and the other comprising 38 experimentally confirmed cases of rational design of the cofactor specificity, revealed the nearly perfect performance of the two methods. The Rossmann-toolbox protocols can be accessed via the webserver at https://lbs.cent.uw.edu.pl/rossmann-toolbox and are available as a Python package at https://github.com/labstructbioinf/rossmann-toolbox. Key pointsO_LIThe Rossmann fold encompasses a multitude of diverse enzymes involved in most of the essential cellular pathways C_LIO_LIProteins belonging to the Rossmann fold co-evolved with their nucleoside-based cofactors and require them for the functioning C_LIO_LIManipulating the cofactor specificity is an important step in the process of enzyme engineering C_LIO_LIWe developed an end-to-end pipeline for the prediction and design of the cofactor specificity of the Rossmann fold proteins C_LIO_LIOwing to the utilization of deep learning approaches the pipeline achieved nearly perfect accuracy C_LI

bioinformatics

Target2DeNovoDrug : a novel programmatic tool for deep learning based de novo drug design for a target of interest

The past decade has seen a surge in the range of application data science, machine learning, deep learning, and AI methods to drug discovery. The presented work involves an assemblage of a variety of AI methods for drug discovery along with the incorporation of in silico techniques to provide a holistic tool for automated drug discovery. When drug candidates are required to be identified for a particular drug target of interest, the user is required to provide the tool target signatures in the form of an amino acid sequence or its corresponding nucleotide sequence. The tool collects data registered on PubChem required to perform an automated QSAR and with the validated QSAR model, prediction and drug lead generation are carried out. This protocol we call Target2Drug. This is followed by a protocol we call Target2DeNovoDrug wherein novel molecules with likely activity against the target are generated de novo using a generative LSTM model. It is often required in drug discovery that the generated molecules possess certain properties like drug-likeness, and therefore to optimize the generated de novo molecules toward the required drug-like property we use a deep learning model called DeepFMPO, and this protocol we call Target2DeNovoDrugPropMax. This is followed by the fast automated AutoDock-Vina based in silico modeling and profiling of the interaction of optimized drug leads and the drug target. This is followed by an automated execution of the Molecular Dynamics protocol that is also carried out for the complex identified with the best protein-ligand interaction from the AutoDock-Vina based virtual screening. The results are stored in the working folder of the user. The code is maintained, supported, and provide for use in the following GitHub repository https://github.com/bengeof/Target2DeNovoDrugPropMax

bioinformatics

A program to automate the discovery of drugs for West Nile and Dengue virus -- programmatic screening of over a billion compounds on PubChem, generation of drug leads and automated In Silico modelling

Our work is composed of a python program for programmatic data mining of PubChem to collect data to implement a machine learning based AutoQSAR algorithm to generate drug leads for the flaviviruses - Dengue and West Nile. The drug leads generated by the program are feed as programmatic inputs to AutoDock Vina package for automated In Silico modelling of interaction between the compounds generated as drug leads by the program and the chosen Dengue and West Nile drug target methyltransferase, whose inhibition leads to the control of viral replication. The machine learning based AutoQSAR algorithm involves feature selection, QSAR modelling, validation and prediction. The drug leads generated each time the program is run is reflective of the constantly growing PubChem database is an important dynamic feature of the program which facilitates fast and dynamic drug lead generation against the West Nile and Dengue virus in way which is reflective of the constantly growing PubChem database. The program prints out the top drug leads after screening PubChem library which is over a billion compounds. The leads generated by the program are fed as programmatic inputs to an In Silico modelling package. The interaction of top drug lead compounds generated by the program and drug targets of West Nile and Dengue virus, was modelled in an automated way through programmatic commands. Thus our program ushers in a new age of automatic ease in the virtual drug screening and drug identification through programmatic data mining of chemical data libraries and drug lead generation through machine learning based AutoQSAR algorithm and an automated In Silico modelling run through the program to study the interaction between the drug lead compounds and the drug target protein of West Nile and Dengue virus

bioinformatics